English
Deutsch
Русский
عربي
Prim. Univ. Prof. Dr. Amir Kurtaran
Austria
About
Prim. Univ. Prof. Dr. Amir Kurtaran completed his specialist training in internal medicine and nuclear medicine at the General Hospital of Vienna and habilitated in nuclear medicine in 1998. His scientific focus includes nuclear medicine diagnostics and therapy, particularly in internal oncology, gastroenterology, urology, and neuroendocrine tumors, as well as the diagnosis and treatment of thyroid diseases. He is also an expert in positron emission tomography (PET) with a focus on oncology, peptide receptor diagnostics in cancer medicine, and medical radiation protection. He is an active member of several international scientific societies and has contributed to the development of medical guidelines as well as numerous research projects. Furthermore, he has received numerous awards, including the Mallinckrodt Research Award and the Erste Bank Research Award. As an inventor, he developed the patented multi-needle biopsy device for thyroid nodules (THYROSAMPLER®), which has been in clinical use since 2005.
Certificates
- The Journal of Nuclear Medicine Editorial Board Award, USA 1995 (co-author)
- Austrian Society of Nuclear Medicine, Mallinckrodt Förderungspreis 1995, for the paper "Tc-99m-Galactosyl-Neoglyco-Albumin Combined with Iodine-123I-Tyr-(A14)-Insulin Visualizes Human Hepatocellular Carcinomas" (first author)
- Poster Award for Nuclear Medicine of the Austrian Society of Internal Medicine 1995, for the paper "Combined Use of 111In-OCT and 123I-VIP in the localization of medullary thyroid carcinoma" (first author)
- Austrian Society of Nuclear Medicine, Mallinckrodt Förderungspreis 1994, for the paper Vasoactive Intestinal Peptide-Receptor Imaging for the localization of Intestinal Adenocarcinomas and Endocrine tumors. I-123-labeled-VIP (Vasoactive intest.
- Austrian Society of Nuclear Medicine, Mallinckrodt Promotion Prize 1996, for the paper Comparison of 123I-VIP receptor scanning and TAG-72 antigen scanning (Oncoscint) in pt. with Gastrointestinal cancer (coauthor)
- Research Award of Erste Bank 1998, for the work Modified LDL decreases the bindingof prostagglandin E2 I2 and E1 on Monocyst in patients with periferal vascular disease (coauthor)
- Turkish Research Institute of Science and Technology: I. Prize for Chemistry, Istanbul, 1977 (first author)
- Turkish Research Institute of Science and Technology: Promotional Prize for Mathematics, Istanbul, 1977 (first author)
Membership
- Society of Nuclear Medicine
- European Association of Nuclear Medicine
- Turkish Association of Nuclear Medicine
- Austrian Society of Nuclear Medicine
- Austrian Society for Internal Medicine
- Professional Association of Austrian Nuclear Physicians
- Association for Medical Radiation Protection
Experience
- Training as "Specialist for Internal Medicine General Hospital of the City of Vienna at the II University Hospital, the II University Hospital for Gastroenterology and Hepatology and the University Hospital for Cardiology1985 - 1991
- Training as "Specialist in Nuclear Medicine" at the General Hospital of the City of Vienna, University Clinic for Nuclear Medicine1991 - 1993
- Habilitation as university lecturer in nuclear medicine1997 - 1998
Education
- Study visit at Memorial Sloan Kettering Cancer Center Nuclear Medicine Service, Clinical PET, New York, USA1998 - 1999
- Study of human medicine in Istanbul/Turkey1976 - 1982
- General medicine practice in Sakarya/Turkey1982 - 1985
Services
- Nuclear medicine diagnostics and therapy (internal oncology; gastroenterology; urology; neuroendocrine tumors)
- Diagnostics and therapy of thyroid diseases
- Positron emission tomography
- Focus on oncology Peptide receptor diagnostics in oncology
- Medical radiation protection